Bacil Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/05/2025 ,inter alia, to consider and approve 1. Approval of the Audited Financial ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bacil Pharma Ltd has informed BSE that its Board of Directors will meet on Monday, 26th May 2025. The main agenda item is to consider and approve the Audited Financial Results for the quarter ended 31st March 2025 (Q4 FY25). Additionally, the Board may take up any other business with the Chairperson's permission. The filing is a standard regulatory intimation under SEBI LODR Regulation 29, and no actual financial figures have been disclosed yet. Signed by Mr. Prakash Shah, Whole Time Director.
This is a routine advance notice and does not move the stock. Investors should watch the actual audited results announcement on or after 26th May 2025 for any material impact on the stock.